Safety, tolerability and pharmacokinetics and pharmacodynamics of HL2351, a novel hybrid fc-fused interleukin-1 receptor antagonist, in healthy subjects: A first-in-human study. Br J Clin Pharmacol.
Pubmed URL : https://www.ncbi.nlm.nih.gov/pubmed/31658396/

Pharmacokinetics of human antithrombin III concentrate in the immediate postoperative period after liver transplantation.
Pubmed URL : https://www.ncbi.nlm.nih.gov/pubmed/31840271/

Pharmacokinetic Characteristics and Limited Sampling Strategies for Therapeutic Drug Monitoring of Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections.
Pubmed URL : https://www.ncbi.nlm.nih.gov/pubmed/30299430/

Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity.
Pubmed URL : https://www.ncbi.nlm.nih.gov/pubmed/30309203/

Characteristics of sauna deaths in Korea in relation to different blood alcohol concentrations.

Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium-competitive acid blocker, in healthy male subjects.

Effect of plasma membrane monoamine transporter genetic variants on pharmacokinetics of metformin in humans.

Evaluation of the effects of food on levodropropizine controlled-release tablet and its pharmacokinetic profile in comparison to that of immediate-release tablet.

A post hoc analysis of intra-subject coefficients of variation in pharmacokinetic measures to calculate optimal sample sizes for bioequivalence studies.

Safety, Tolerability, and Pharmacokinetic Characteristics of a Novel Nonopioid Analgesic, VVZ-149 Injections in Healthy Volunteers: A First-in-Class, First-in-Human Study.

Performance of the Minto model for the target-controlled infusion of remifentanil during cardiopulmonary bypass.

Prediction of serum theophylline concentrations and cytochrome P450 1A2 activity by analyzing urinary metabolites in preterm infants.

Effects of CYP2C19 Genetic Polymorphisms on PK/PD Responses of Omeprazole in Korean Healthy Volunteers

The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans.

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers.

Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase-4 inhibitor, evogliptin (DA-1229).

Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects.

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs.

Evaluation of factors associated with drug-induced liver injury using electronic medical records.

Inhibition of the multidrug and toxin extrusion (MATE) transporter by pyrimethamine increases the plasma concentration of metformin but does not increase antihyperglycaemic activity in humans.
Pubmed URL : https://www.ncbi.nlm.nih.gov/pubmed/29926439/